SEER Q4 2022 Earnings — Seer, Inc. Revenue & Financial Results | Market Cap Arena

SEERSeer, Inc.

$101M

Q4 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$4M+27.3% YoY

Gross Profit

$2M40.2% margin

Operating Income

-$25M-646.2% margin

Net Income

-$23M-583.4% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

-2.4%

Cash Flow

Operating Cash Flow

-$14M

Free Cash Flow

-$19M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$488M

Total Liabilities

$41M

Stockholders' Equity

$447M

Cash & Equivalents

$53M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4M	$3M	+27.3%
Gross Profit	$2M	-$442,000	+450.9%
Operating Income	-$25M	-$20M	-25.3%
Net Income	-$23M	-$20M	-14.1%

Revenue Segments

Related Party

$2M45%

Product

$1M37%

Service

$709,00018%